PRODUCTID,PRODUCTNDC,PRODUCTTYPENAME,PROPRIETARYNAME,PROPRIETARYNAMESUFFIX,NONPROPRIETARYNAME,DOSAGEFORMNAME,ROUTENAME,STARTMARKETINGDATE,ENDMARKETINGDATE,MARKETINGCATEGORYNAME,APPLICATIONNUMBER,LABELERNAME,SUBSTANCENAME,ACTIVE_NUMERATOR_STRENGTH,ACTIVE_INGRED_UNIT,PHARM_CLASSES,DEASCHEDULE
0409-6509_44e1fb49-2a7f-4149-acc9-27d362047c71,0409-6509,HUMAN PRESCRIPTION DRUG,Vancomycin Hydrochloride,,VANCOMYCIN HYDROCHLORIDE,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,20050606,,ANDA,ANDA063076,"Hospira, Inc.",VANCOMYCIN HYDROCHLORIDE,500,mg/10mL,"Glycopeptide Antibacterial [EPC],Glycopeptides [Chemical/Ingredient]",
0143-9908_23f89437-006e-4487-b224-f48045dab0b5,0143-9908,HUMAN PRESCRIPTION DRUG,NAPROXEN,,naproxen sodium,"TABLET, FILM COATED",ORAL,19960514,,ANDA,ANDA074480,West-Ward Pharmaceutical Corp,NAPROXEN SODIUM,550,mg/1,"Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
0641-6126_a5957925-ce8b-4bbc-97ff-99600bbda304,0641-6126,HUMAN PRESCRIPTION DRUG,Morphine Sulfate,,Morphine Sulfate,INJECTION,INTRAVENOUS,20150603,,ANDA,ANDA205758,West-Ward Pharmaceuticals Corp.,MORPHINE SULFATE,8,mg/mL,"Full Opioid Agonists [MoA],Opioid Agonist [EPC]",CII
